The Computational Life Science Disease Control (CLS-DC) group at Bayer acts to enable data- and model informed innovation and decision making within the Small Molecules (SMol) group in general & the Disease Control indication in particular to improve the success rate in the discovery and optimization process of novel fungicidal compounds with high commercial potential.
At equal importance the team will ensure the drive of digital maturity in the SMol organization with a special focus on Disease Control indication